keyword
https://read.qxmd.com/read/38639956/-research-progress-on-mechanism-and-preventive-measures-of-retrograde-ejaculation-after-benign-prostatic-hyperplasia-surgery
#1
JOURNAL ARTICLE
Guo-Rong Yang, Kai-Kai Lü, Yang-Yang Wu, Tao Song
Benign prostatic hyperplasia (BPH) is a common disease in middle-aged and elderly men. It's first-line therapy is drugs. But with the progression of the disease or side effects of drugs, surgical treatment will become a better choice. However, either transurethral resection of the prostate, the standard procedure, or enucleation or resection of the prostate based on various laser platforms or plasma technologies cause a high incidence of retrograde ejaculation in their postoperative follow-up. In the past, retrograde ejaculation was usually regarded as the cost of benign prostatic hyperplasia surgery...
December 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38582650/tolerability-of-olaparib-combined-with-abiraterone-in-patients-with-metastatic-castration-resistant-prostate-cancer-further-results-from-the-phase-3-propel-trial
#2
JOURNAL ARTICLE
Fred Saad, Andrew J Armstrong, Mototsugu Oya, Karina Vianna, Mustafa Özgüroğlu, Craig Gedye, Gary L Buchschacher, Ji Youl Lee, Urban Emmenegger, Jiri Navratil, Juan Antonio Virizuela, Anibal Salazar, Denis Maillet, Hiroji Uemura, Jeri Kim, Emma Oscroft, Laura Barker, Arnold Degboe, Noel W Clarke
BACKGROUND: The PROpel study (NCT03732820) demonstrated a statistically significant progression-free survival benefit with olaparib plus abiraterone versus placebo plus abiraterone in the first-line metastatic castration-resistant prostate cancer (mCRPC) setting, irrespective of homologous recombination repair mutation status. OBJECTIVE: We report additional safety analyses from PROpel to increase clinical understanding of the adverse-event (AE) profiles of olaparib plus abiraterone versus placebo plus abiraterone...
April 5, 2024: European Urology Oncology
https://read.qxmd.com/read/38566390/prostatic-fossa-pseudoaneurysm-after-robot-assisted-radical-prostatectomy-rarp-a-case-report
#3
JOURNAL ARTICLE
Vasco Manuel Almeida Rodrigues, Carlos Silva, Nuno Dias, José Teixeira de Sousa, Luís Afonso Morgado
BACKGROUND RARP is an established procedure in treatment of localized prostate cancer. Hemorrhagic complications in the postoperative period are rare, but sometimes life-threatening. Adequate monitoring and prompt intervention in these unusual scenarios rely on clinical judgement and blood and imaging studies. Prostatic fossa pseudoaneurysm formation after RARP is very rare and its etiology is not well known; it may be related to small vessel trauma. It becomes apparent with the development of hematuria 1-6 weeks after surgery...
April 3, 2024: American Journal of Case Reports
https://read.qxmd.com/read/38565890/value-of-magnetic-resonance-angiography-before-prostatic-artery-embolization-for-intervention-planning
#4
JOURNAL ARTICLE
Matthias Boschheidgen, Tim Ullrich, Rouvier Al-Monajjed, Farid Ziayee, Rene Michalski, Andrea Steuwe, Peter Minko, Peter Albers, Gerald Antoch, Lars Schimmöller
Knowledge about anatomical details seems to facilitate the procedure and planning of prostatic artery embolization (PAE) in patients with symptomatic benign prostatic hyperplasia (BPS). The aim of our study was the pre-interventional visualization of the prostatic artery (PA) with MRA and the correlation of iliac elongation and bifurcation angles with technical success of PAE and technical parameters. MRA data of patients with PAE were analysed retrospectively regarding PA visibility, PA type, vessel elongation, and defined angles were correlated with intervention time, fluoroscopy time, dose area product (DAP), cumulative air kerma (CAK), contrast media (CM) dose and technical success of embolization...
April 2, 2024: Scientific Reports
https://read.qxmd.com/read/38563908/post-embolization-syndrome-after-prostatic-artery-embolization-where-are-we-and-where-to-next
#5
EDITORIAL
Nassir Rostambeigi
No abstract text is available yet for this article.
April 2, 2024: Cardiovascular and Interventional Radiology
https://read.qxmd.com/read/38558593/management-of-renal-artery-aneurysms-and-an-arteriovenous-shunt-in-a-hemophilic-patient-a-case-report
#6
Yehya Tlaiss, Aziz M Najjar, Mohamad Tlais, Peter Noun, Imad Ghantous
This case report details the management of a 66-year-old male with hemophilia A (HA) who presented with recurrent hematuria, and was found to have renal artery aneurysms and was subsequently diagnosed with a renal arteriovenous (AV) shunt. While the primary focus centers on the successful endovascular coil embolization of renal artery aneurysms, the concomitant presence of the AV shunt accentuates the significance of this case. Imaging techniques were crucial in the discovery of renal aneurysms and the diagnosis of the AV shunt malformation of the renal artery...
February 2024: Curēus
https://read.qxmd.com/read/38547919/-minimally-invasive-surgical-techniques-mist-shedding-light-on-the-mist
#7
JOURNAL ARTICLE
Christopher Netsch, Andreas J Gross, Thomas Rw Herrmann, Jonas Herrmann, Benedikt Becker
As life expectancy increases and there is growing demand for BPH treatments, innovative technologies have been developed, allowing for swift recovery, symptom relief, low complication rates, and the possibility of performing procedures on an outpatient basis, often under local anaesthesia. This review aims to describe the outcomes of newly developed minimally-invasive surgical therapies (MIST) for BPH treatment in terms of functional voiding parameters and sexual function. These therapies are categorized into primarily ablative (Aquablation [Aquabeam]), non-ablative (Prostatic Urethral Lift (PUL, Urolift), temporary implantable devices [iTind]), and secondarily ablative procedures (convective water vapor ablation, Rezum, Prostate Artery Embolization [PAE])...
March 28, 2024: Aktuelle Urologie
https://read.qxmd.com/read/38525003/double-microballoon-occluded-ethanol-embolization-for-pelvic-arteriovenous-malformation-a-case-report
#8
Keigo Osuga, Naoki Yokota, Kazuhiro Yamamoto, Hiroki Matsutani, Kiyohito Yamamoto, Hiroshi Juri, Hideki Ozawa, Takahiro Katsumata
A 40-year-old man was incidentally found to have right-sided pelvic arteriovenous malformation (AVM) with an aneurysmal dominant outflow vein (DOV). The AVM had two main feeding arteries forming a cluster of fine vessels shunt to the DOV. As transvenous approach was impossible due to anatomical difficulty, transarterial ethanol embolization was performed under simultaneous double microballoon occlusion of the two feeding arteries in combination with protective coil embolization of the prostatic branches. Ethanol (13 mL) was intermittently injected from both microballoon catheters until the AV shunt was completely occluded...
March 1, 2024: Interventional radiology
https://read.qxmd.com/read/38523947/successful-robot-assisted-simple-prostatectomy-years-after-a-prostate-artery-embolization-a-case-report-and-review-of-the-literature
#9
Kale Moreland, Gabrielle R Yankelevich, Paul Womble
Simple prostatectomy (SP) can be utilized for patients with large prostates with lower urinary tract symptoms. Prostate artery embolization (PAE) does not have robust clinical evidence to support its use in treating urinary symptoms; however, it is an effective treatment for refractory hematuria from a prostatic source. There have been limited papers regarding preoperative PAE prior to SP. However, there are no papers regarding the feasibility of delayed SP after PAE. We present, to our knowledge, the first paper demonstrating a successful robot-assisted SP years after a PAE in a patient with a 380g prostate with recurrent refractory gross hematuria...
February 2024: Curēus
https://read.qxmd.com/read/38441098/multicenter-quantification-of-radiation-exposure-and-associated-risks-for-prostatic-artery-embolization-in-1476-patients
#10
MULTICENTER STUDY
Raj Ayyagari, Saumik Z Rahman, Kevin Grizzard, Adel Mustafa, Lawrence H Staib, Rasha S Makkia, Shivank Bhatia, Tiago Bilhim, Francisco C Carnevale, Clifford Davis, Aaron Fischman, Ari Isaacson, Timothy McClure, Justin McWilliams, Charles Nutting, Andrew Richardson, Riad Salem, Marc Sapoval, Hyeon Yu
Background Prostatic artery embolization (PAE) is a safe, minimally invasive angiographic procedure that effectively treats benign prostatic hyperplasia; however, PAE-related patient radiation exposure and associated risks are not completely understood. Purpose To quantify radiation dose and assess radiation-related adverse events in patients who underwent PAE at multiple centers. Materials and Methods This retrospective study included patients undergoing PAE for any indication performed by experienced operators at 10 high-volume international centers from January 2014 to May 2021...
March 2024: Radiology
https://read.qxmd.com/read/38441094/benign-prostatic-hyperplasia-time-to-upgrade-treatment-guidelines-regarding-prostatic-artery-embolization
#11
EDITORIAL
M Mahesh
No abstract text is available yet for this article.
March 2024: Radiology
https://read.qxmd.com/read/38440742/prostatic-artery-embolization-via-inferior-epigastric-collateral-in-chronic-total-occlusion-of-the-anterior-division-of-the-left-internal-iliac-artery
#12
Le Nguyen Vu, Le Thanh Dung, Than Van Sy, Le Quy Thien, Ngo Quang Duy, Pham Huu Khuyen
Prostatic artery embolization (PAE) is one of the new treatment therapies for lower urinary tract symptoms in male patients with benign prostatic hyperplasia. PAE is considered a minimally invasive option besides other famous traditional therapies such as transurethral resection of the prostate (TURP) and open surgery. Additionally, PAE has a specific advantage in managing the elderly group and underlying health conditions like anticoagulation. In this article, we presented the case of an 83-year-old male patient who has chronic urinary retention due to benign prostatic hyperplasia, left coronary artery stent placement, and long-term anticoagulation...
May 2024: Radiology Case Reports
https://read.qxmd.com/read/38437821/bilateral-choroidal-detachments-following-novel-car-t-cell-immunotherapy-regimen
#13
JOURNAL ARTICLE
Timothy J Goblirsch, Vincent Huang, Albert Maguire, Apoorv P Chebolu
PURPOSE: To describe a vision-threatening adverse event of a novel CAR T-cell immunotherapy for metastatic prostate cancer. METHODS: Observational Case Report. PATIENT: 77-year-old male with history of metastatic prostate cancer and pulmonary embolism enrolled in a clinical trial investigating the use of CAR T-cell immunotherapy for treatment of metastatic prostate cancer presented with a subjective left temporal visual disturbance. RESULTS: The patient was found to have bilateral extensive choroidal detachments on examination...
March 4, 2024: Retinal Cases & Brief Reports
https://read.qxmd.com/read/38421488/the-pathogenesis-of-cancer-associated-thrombosis
#14
REVIEW
Kohei Tatsumi
Patients with cancer have a higher risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), compared to the general population. Cancer-associated thrombosis (CAT) is a thrombotic event that occurs as a complication of cancer or cancer therapy. Major factors determining VTE risk in cancer patients include not only treatment history and patient characteristics, but also cancer type and site. Cancer types can be broadly divided into three groups based on VTE risk: high risk (pancreatic, ovarian, brain, stomach, gynecologic, and hematologic), intermediate risk (colon and lung), and low risk (breast and prostate)...
February 29, 2024: International Journal of Hematology
https://read.qxmd.com/read/38420752/transperineal-microwave-thermoablation-for-benign-prostatic-hyperplasia-related-lower-urinary-tract-symptoms-in-an-elderly-patient
#15
JOURNAL ARTICLE
Yaşar Türk, İsmail Devecioğlu, Nusret Can Çilesiz, Barış Nuhoğlu
Transperineal prostate microwave thermoablation (TPMT) has been established as a safe means of treating benign prostatic hyperplasia (BPH); however, its effectiveness in addressing BPH-related lower urinary tract symptoms (LUTS) remains unexplored. This case study aims to evaluate the efficacy of TPMT in LUTS attributed to BPH. An 84-year-old man with LUTS due to BPH-induced bladder outlet obstruction, unresponsive to previous medical treatments, and failed prostate artery embolization, underwent TPMT. Three coaxial needles were positioned at the midline, right, and left sides of the hypertrophic transitional zone of the prostate...
February 29, 2024: Diagnostic and Interventional Radiology: Official Journal of the Turkish Society of Radiology
https://read.qxmd.com/read/38416176/prostatic-artery-embolization-in-patients-with-advanced-prostate-cancer-a-prospective-single-center-pilot-study
#16
JOURNAL ARTICLE
Orlando Burkhardt, Dominik Abt, Lukas Hechelhammer, Olaf Kim, Aurelius Omlin, Hans-Peter Schmid, Daniel Engeler, Valentin Zumstein, Gautier Müllhaupt
PURPOSE: To assess efficacy and safety of prostatic artery embolization (PAE) in patients with advanced prostate cancer (PCa). MATERIALS AND METHODS: In this prospective single-center, single-arm, pilot study, 9 men with advanced PCa underwent PAE. PAE was performed with the use of 250-400 µm Embozene microspheres (Boston Scientific, Natick, Massachusetts, USA). International Prostate Symptoms Score (IPSS), urinary peak flow (Qmax) and post-void residual urine volume (PVR) was assessed at 12 weeks and up to 12 months...
February 28, 2024: Cardiovascular and Interventional Radiology
https://read.qxmd.com/read/38413272/prostate-artery-embolization-using-liquid-embolic-agents-is-it-the-future-or-just-a-trend
#17
EDITORIAL
Tom Boeken
No abstract text is available yet for this article.
February 26, 2024: Diagnostic and Interventional Imaging
https://read.qxmd.com/read/38395873/predictive-accuracy-of-boosted-regression-model-in-estimating-risk-of-venous-thromboembolism-following-minimally-invasive-radical-surgery-in-pharmacological-prophylaxis-na%C3%A3-ve-men-with-prostate-cancer
#18
JOURNAL ARTICLE
Chie Hui Leong, Sushil Rodrigues Ranjan, Anna Javed, Basim S O Alsaedi, Ghulam Nabi
BACKGROUND: Venous thromboembolism (VTE) is a potentially life-threatening but preventable complication after urological surgery. Physicians are faced with the challenges of weighing the risks and benefits of thromboprophylaxis given scanty evidence for or against and practice variation worldwide. OBJECTIVE: The primary objective of the study was to explore the possibility of a risk-stratified approach for thromboembolism prophylaxis following radical prostatectomy...
February 23, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38371212/one-year-outcomes-after-prostate-artery-embolization-versus-laser-enucleation-a-network-meta-analysis
#19
REVIEW
Ansh Bhatia, Joao Gabriel Porto, Aneesha Maini, Deepak Langade, Thomas R W Herrmann, Hemendra Navinchandra Shah, Shivank Bhatia
BACKGROUND: Although holmium laser enucleation (HoLEP) is considered a size-independent procedure for treatment of an enlarged prostate, prostate artery embolization (PAE) is emerging as an alternative modality to treat moderate and large benign prostatic hyperplasia. This study aims to compare the early post-operative and short-term efficacy of PAE and HoLEP. METHODS: PubMed, Cochrane Library and EMBASE databases were searched. Network meta-analysis was performed following PRISMA-N-guidelines...
March 2024: BJUI compass
https://read.qxmd.com/read/38371211/transperineal-drainage-of-prostate-abscesses-a-minimally-invasive-low-risk-management-strategy-that-yields-satisfactory-results
#20
REVIEW
David Scholtz, Ali Hooshyari, Lodewikus Petrus Vermeulen, Flavio Vasconcelos Ordones
OBJECTIVES: In this narrative review, we aim to present two cases of transperineal drainage of prostate abscesses with a good clinical outcome. Furthermore, we reviewed the literature on this treatment approach and aim to propose a minimally invasive protocol for managing this rare condition. PATIENTS AND METHODS: Our patients are 33- and 61-year-old males who both underwent uncomplicated transperineal drainage of prostate abscess with the use of a Precision Point device with rapid clinical improvement and complete resolution of the abscess within the follow-up period...
March 2024: BJUI compass
keyword
keyword
4247
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.